Samsung Biologics
207940.KS
#349
Rank
$44.84 B
Marketcap
$627.06
Share price
-3.01%
Change (1 day)
-16.48%
Change (1 year)

Earnings for Samsung Biologics (207940.KS)

Earnings in 2022 (TTM): $0.58 B

According to Samsung Biologics 's latest financial reports the company's current earnings (TTM) are $0.58 B. In 2021 the company made an earning of $0.49 B an increase over its 2020 earnings that were of $0.24 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Samsung Biologics from 2016 to 2022

Annual earnings

Year Earnings Change
2022 (TTM)$0.58 B18.62%
2021$0.49 B103.97%
2020$0.24 B57.39%
2019$0.15 B-45.46%
2018$0.28 B-390%
2017-$0.1 B-46.74%
2016-$0.19 B